etomoxir has been researched along with Acidosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbet, C; Deskeuvre, M; Dierge, E; Feron, O; Frédérick, R; Lan, J; Messens, J; Riant, O | 1 |
| Kler, RS; Melde, K; Sherratt, HS; Turnbull, DM | 1 |
2 other study(ies) available for etomoxir and Acidosis
| Article | Year |
|---|---|
Targeting cancer cells in acidosis with conjugates between the carnitine palmitoyltransferase 1 inhibitor etomoxir and pH (low) insertion peptides.
Topics: Acidosis; Carnitine O-Palmitoyltransferase; Epoxy Compounds; Humans; Hydrogen-Ion Concentration; Neoplasms; Peptides | 2022 |
Organic aciduria in fasted rats caused by 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate (etomoxir).
Topics: Acidosis; Animals; Carboxylic Acids; Dicarboxylic Acids; Epoxy Compounds; Fasting; Hypoglycemic Agents; Male; Mitochondria, Liver; Palmitates; Rats; Rats, Inbred Strains | 1991 |